Revenue Breakdown
Composition ()
No data
Revenue Streams
Thermo Fisher Scientific Inc (TMO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 42.4% of total sales, equivalent to $4.61B. Other significant revenue streams include Service and Instruments. Understanding this composition is critical for investors evaluating how TMO navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Thermo Fisher Scientific Inc maintains a gross margin of 41.02%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 18.80%, while the net margin is 16.13%. These profitability ratios, combined with a Return on Equity (ROE) of 13.02%, provide a clear picture of how effectively TMO converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TMO competes directly with industry leaders such as ABT and ISRG. With a market capitalization of $193.58B, it holds a significant position in the sector. When comparing efficiency, TMO's gross margin of 41.02% stands against ABT's 53.44% and ISRG's 66.44%. Such benchmarking helps identify whether Thermo Fisher Scientific Inc is trading at a premium or discount relative to its financial performance.
